The CDE of China's NMPA has granted BioCity's endothelin receptor type A (ETA) antagonist, SC0062, a second BTD.

The London Biotechnology Show 2025, held from 18 to 19 June, encompassed a range of sessions on automation, regulation, and ...

While the UK continues its close 25-year partnership with Gavi, the US is halting funding to the organisation. In a move that ...

The US FDA has granted approval for a label update to Eli Lilly and Company's Amyvid (florbetapir F 18 injection) for use ...

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...

Novartis has completed its previously announced acquisition of Regulus Therapeutics for $1.7bn, strengthening its renal ...

Shares in Vor Bio opened 45% higher on 26 June following the announcement the day prior. Credit: ADragan via Shutterstock. A month and a half after winding operations and laying off almost all its ...